AI-generated summary
The authors describe a single 15-day-old neonate with soft-tissue necrosis after BCG vaccination who received allogeneic adipose-derived mesenchymal stem cell infusions together with daily photobiomodulation. They report progressive reduction in lesion depth and complete wound closure 70 days after the first cell therapy session. As a single case report, the findings cannot establish cause and effect, and the authors call for controlled trials.
- Participants
- 1
- Who or what was studied
- A single 15-day-old neonate with peripheral ischemia and right upper limb abscess following BCG vaccination, with protein C and S deficiencies and purpura fulminans.
- Limits stated in the abstract
- This is a single case report, so no control group or generalizable conclusions can be drawn, and the abstract does not state the wavelengths used for photobiomodulation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
A 15-day-old neonate was admitted to a neonatal intensive care unit with peripheral ischemia and a right upper limb abscess following Bacillus Calmette-Guérin (BCG) vaccination. Laboratory findings revealed protein C and S deficiencies with elevated d-dimer levels. Imaging demonstrated a cerebral ischemic lesion secondary to coagulopathy, supporting a diagnosis of purpura fulminans. Initial management included abscess drainage followed by extensive surgical debridement of necrotic tissue, anticoagulation, and partial wound suturing. After the third debridement, the infant received four weekly infusions of 1 × 107 allogeneic adipose-derived mesenchymal stem cells, suspended in 2 mL of saline solution, and administered across 10-15 intralesional and perilesional injection sites. Daily photobiomodulation therapy was used as an adjunctive treatment for analgesia and tissue regeneration. Following the first cell therapy session, progressive reduction in lesion depth and enhanced vascularization were observed, culminating in complete wound closure 70 days after the initial cell therapy session. This approach may support future advances in cell therapy and regenerative medicine for the treatment of difficult-to-heal wounds in neonates and provides a rationale for prospective, randomized, controlled clinical trials.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Case report, Photobiomodulation therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.